Jouvence Pharmaceuticals, Research Corporation Technologies deal

Jouvence received an exclusive license from Research Corp. for the longevity-assurance gene (LAG1) in yeast and its human homolog. Jouvence plans to use the gene and its product, LAG1p, as a component...